ALD Connect

Characterization of Cholesterol Pathways in ALD Pathophysiology

Building the Future for ALD: Paradigm Shifts and Therapeutic Opportunities

Two Tales to Tell: Gene Therapy 2.0 and Anti-MLC

The Grey Zone Project Risk-Based Classification of ABCD1 Variants in X-linked Adrenoleukodystrophy

International Study of Meaningfulness of Sway and Gait to Assess AMN Sensorimotor Progression

Patient Panel

2025 ALD Connect Awards

Gene Therapy Vectors

2024 ALD Connect Emerging Investigators

CRISPR/Cas9 and Screening for the Levels of ABCD Transporters

Novel Brain Iron Imaging

Minoryx Therapeutics: A Clinical Development Update

Gene Editing Approaches

Welcome to the Patient Learning Academy

ALD Connect Collaborative Research Network Update

Ask the Experts

Closing Remarks

Fireside Chat: The Evolving ALD Landscape and Therapy Development

Genotype Classification and C26-LPC Levels Predict ALD Symptoms in Boys Identified via NBS

ALD Connect - Collaborative Research Network

ALD Connect - Who We Are

Grief 101: Updates, Hard Truths, and Myths

ALD Connect - Protocol for Making Dried Blood Spot Cards at Home

23 Ask the Experts: Adults

25 Closing Remarks - O'Sullivan Fortin

24 Doing What Matters: Embracing Psychological Flexibility Amidst Uncertainty - Clifford

14 Minoryx Therapeutics Update - Mistry

06 Changing the Practice of Medicine for ALD – Lund

10a Lipodomic Fingerprinting of X Linked ALD Blood Spots -Jaspers

10b Transcriptomic and Lipidomic Signatures in ALD - Demmitt Rice